62 WELLNESS 0 0
500
500
1000
1000
1500
1500
2000
2000
2500
2500
3000
3000
3500
3500
0
500
1000
1500
2000
2500
3000
0
500
1000
1500
2000
2500
3000
Figure 1: Representative facial macrophotographs evaluated using CieLab software demonstrate a visible reduction in brown spots. Quantitative analysis indicated a statistically significant decrease in the mean value by 3.77% (p = 0.0001) after 42 days of supplementation with CCmc compared to baseline
and anti-glycation properties.12,13,14 It inhibits NF-
kB activation, reduces reactive oxygen species, and modulates cytokine production, making it a powerful ally against oxidative stress.15,16 For skin health, curcumin neutralizes free
radicals, supports collagen integrity, and calms inflammation.17
However, curcumin’s potential
has been historically limited by poor solubility and low bioavailability—until microencapsulation technology unlocked its promise.18,19,20
Microencapsulation: unlocking potential One of the greatest challenges in nutraceutical formulation is bioavailability.18
Many active
ingredients, despite their proven benefits, struggle to deliver results because they are poorly absorbed, unstable, or unpleasant in taste. Curcumin is a prime example: its low solubility
and rapid metabolism have historically limited its efficacy in beauty-from-within applications.19,20 Lubrizol Nutraceuticals addressed this
challenge with Curcushine™ microcapsules (CSmc), using patented microencapsulation technology to deliver curcuminoids in a water- dispersible format while maintaining the original natural extract’s curcuminoid proportion— enhancing absorption and systemic delivery without altering their chemical structure.22,23 Similar principles apply to other essential
nutrients. Iron, for instance, supports cell function and collagen synthesis but often causes gastrointestinal discomfort and metallic taste. Through microencapsulation, stabilized iron
PERSONAL CARE MAGAZINE March 2026
ingredients can mask off-taste, prevent oxidation, and improve absorption, enabling consumer- friendly formats such as gummies, sachets, and beverages without the side effects traditionally associated with iron supplementation. Similar to iron, magnesium is an essential
mineral involved in over 300 enzymatic reactions, playing a critical role in skin barrier function and hydration. Despite its importance, magnesium presents formulation challenges. Highly reactive and poorly soluble, it often requires large doses to achieve efficacy, compromising convenience and palatability for consumers. Advances in particle engineering have
transformed magnesium supplementation. Microencapsulation technology enables high elemental concentration in compact, enjoyable formats such as orosoluble sticks and gummies. This approach enhances bioavailability while ensuring a pleasant sensory experience, supporting adherence in daily wellness routines. Micronization and microencapsulation are
core technologies driving modern nutraceutical solutions. These techniques address unmet needs by improving bioavailability and dispersibility, enhancing stability against oxidation and moisture, and optimizing sensory properties such as taste masking and texture control. They also enable versatile applications
for delivery formats that fit today’s consumer lifestyles. This integrated expertise positions innovators as leaders in nutraceutical development, offering not just ingredients but technological platforms that transform
formulation challenges into market-ready solutions.
Clinical validation: science behind the glow The clinical validation of CCmc microcapsules was designed to meet the highest standards of scientific rigour, ensuring that observed benefits were both statistically significant and clinically meaningful. The study employed a monocentric, randomized, double-blind, placebo-controlled design—widely recognized as the gold standard for nutraceutical efficacy trials. Fifty-seven healthy women aged 21 to 50
years participated, with an average age of
43.All presented visible skin imperfections such as fine lines, uneven tone, acne marks, and pigmentation spots. Inclusion criteria ensured stable hormonal status and absence of dermatological conditions or systemic illnesses. Exclusion criteria included recent cosmetic procedures, antioxidant supplement use, or medications affecting skin physiology. Subjects were randomized into two groups:
one received a daily sachet containing two grams of the active formulation delivering 500 milligrams of curcuminoids; the other received an identical
placebo.The intervention lasted six weeks, and all participants used the same neutral topical cream and cleanser to eliminate external skincare influences. Researchers implemented multi-dimensional assessment techniques to capture both visible
www.personalcaremagazine.com
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100 |
Page 101 |
Page 102 |
Page 103 |
Page 104
